Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

Rhea-AI Summary

Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to two new non-executive employees. The awards, granted on February 1, 2025, consist of restricted stock units covering 35,000 shares of Teladoc's common stock. The vesting schedule includes one-third of the shares on the first anniversary of the grant date, with the remaining shares vesting quarterly over the subsequent two years, contingent on continued employment. The awards were approved by the Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.

Positive

• Strategic talent acquisition supported by equity-based compensation
• Structured vesting schedule promotes long-term employee retention

Negative

• Potential dilution of existing shareholders through new stock issuance

PURCHASE, NY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees.

Effective February 1, 2025, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 35,000 shares of Teladoc Health’s common stock, par value $0.001 per share. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com

Media:
Lou Serio
202-569-9715
pr@teladochealth.com

FAQ

How many shares of TDOC stock were granted in the February 2025 inducement awards?

Teladoc Health granted restricted stock units covering 35,000 shares of common stock to two new non-executive employees.

What is the vesting schedule for TDOC's February 2025 inducement awards?

The restricted stock units vest one-third after one year, with the remaining shares vesting quarterly over the following two years, subject to continued employment.

Under which plan were TDOC's February 2025 inducement awards granted?

The awards were granted under Teladoc Health's 2023 Employment Inducement Incentive Award Plan.

How many employees received TDOC inducement awards in February 2025?

Two new non-executive employees received inducement awards from Teladoc Health.